乐观
$4.30
情景价格
$7.250
-0.554 (-7.64%)收盘时
Butterfly Network, Inc. is a digital health business offering care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. Its ultrasound devices can perform whole-body imaging with a single handheld probe. Its Ultrasound-on-Chip makes ultrasound accessible outside of healthcare institutions, while its software is intended to make the product fully integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and any hospital computer system. It markets and sells the Butterfly system, which includes probes, related accessories, and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and its e-commerce channel. It licenses its Ultrasound-on-Chip semiconductor platform for co-development of novel technologies through its Embedded program. Its products consist of iQ3, iQ+, iQ+ Bladder, and Compass AI software.
Butterfly Network Inc is currently not a strong buy due to its recent price decline and negative momentum indicators. The stock is trading at $7.25, with a 5-day change of -12.12% and an RSI of 29.137, indicating oversold conditions. While analysts have set a target price of $10, suggesting a potential upside of 37.93%, the stock's recent performance and negative earnings reports raise concerns. The main risk is the high forward P/E ratio of 0, indicating uncertainty in future earnings.
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Morgan Stanley Sees Growth Potential for eBay

Butterfly Network to Report Q3 2026 Financial Results

Latest Wall Street Rating Updates

Needham Initiates Buy Rating on Butterfly Network

Butterfly Network Executive Sells Shares to Meet Tax Obligations
Butterfly Network, Inc. is a digital health business offering care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. Its ultrasound devices can perform whole-body imaging with a single handheld probe. Its Ultrasound-on-Chip makes ultrasound accessible outside of healthcare institutions, while its software is intended to make the product fully integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and any hospital computer system. It markets and sells the Butterfly system, which includes probes, related accessories, and software subscriptions, to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and its e-commerce channel. It licenses its Ultrasound-on-Chip semiconductor platform for co-development of novel technologies through its Embedded program. Its products consist of iQ3, iQ+, iQ+ Bladder, and Compass AI software. It operates in the Healthcare sector (X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPA industry).
Butterfly Network Inc is currently not a strong buy due to its recent price decline and negative momentum indicators. The stock is trading at $7.25, with a 5-day change of -12.12% and an RSI of 29.137, indicating oversold conditions. While analysts have set a target price of $10, suggesting a potential upside of 37.93%, the stock's recent performance and negative earnings reports raise concerns. The main risk is the high forward P/E ratio of 0, indicating uncertainty in future earnings.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。